Our Blog

Illustration of a computer showing a site and some metrics indicating site status
Articles

How Can Your Site Stand Out On a Clinical Trial Site Feasibility Questionnaire? Track These 3 Metrics.

August 20, 2024

Here are 3 powerful site feasibility metrics to track for questionnaires, plus where to find them if you use StudyTeam for Sites.

Illustration of a man interacting with a list of patient data connected to a site
Articles

Tips for Patient Recruitment and Education from a REIMED Clinical Research Coordinator in South Africa

August 1, 2024

Hear from a clinical research coordinator in our latest blog as he shares tips for patient recruitment and education across his South African community.

Woman interacting with patient info on a clipboard
Articles

A Doctor at Shaare Zedek Medical Center in Israel Talks Challenges and Rewards of Managing a Large Patient Population

July 11, 2024

A doctor at Shaare Zedek Medical Center in Israel talks about research challenges, as well as the clinical trial site’s deep experience. Read the blog.

Illustration of graph matching patients to sites
Articles

3 Principles Behind StudyTeam’s API: How Does It Benefit Sponsors, Sites, Patients, and Patient Recruitment Vendors?

June 27, 2024

OneStudyTeam has established integrations with 32+ patient recruitment vendors. How? Through StudyTeam's API. Read about the benefits.

Illustration of a woman at a desk at a computer looking at work in StudyTeam
Articles

5 Challenges StudyTeam Solves for Fast-Enrolling Clinical Trials

May 31, 2024

Fast-enrolling trials can pose problems, including protocol deviations and a lack of patient diversity. See how StudyTeam solves these challenges and more.

Illustration representing site staff interacting with various StudyTeam features on a laptop
Articles

6 Ways for Clinical Research Coordinators to Reduce Clinical Trial Site Burden

May 24, 2024

Read our blog to see how clinical research coordinators can take steps to reduce clinical trial site burden and improve patient care.